What characterizes maintenance therapy in asthma?

What characterizes maintenance therapy in asthma?

• A. PRN usage based on symptoms
• B. Scheduled daily controller therapy
• C. A specific score on the ACT
• D. Usage of short-acting bronchodilators

Answer: (B)

Maintenance therapy in asthma is characterized by scheduled daily controller therapy. This approach is essential for managing asthma long-term and involves the use of medications that reduce inflammation in the airways and help prevent asthma symptoms. Controller medications, such as inhaled corticosteroids, are taken daily regardless of the presence of symptoms, which helps to stabilize the condition, prevent exacerbations, and maintain control over inflammation. Using scheduled daily controller therapy allows for consistent management of asthma, reducing the risk of acute symptoms and improving overall lung function. This proactive strategy is fundamental to effective asthma care and is distinct from short-term or as-needed medications, which serve different purposes in managing asthma symptoms. In contrast, the other options relate to different aspects of asthma management. PRN (as-needed) use refers mainly to quick-relief medications that address symptoms during asthma exacerbations, while the ACT (Asthma Control Test) measures the control of asthma but is not a therapy in itself. Short-acting bronchodilators are typically used for immediate relief and do not constitute maintenance therapy, which focuses on long-term control of the disease.

Maintenance therapy in asthma is characterized by scheduled daily controller therapy. This approach is essential for managing asthma long-term and involves the use of medications that reduce inflammation in the airways and help prevent asthma symptoms. Controller medications, such as inhaled corticosteroids, are taken daily regardless of the presence of symptoms, which helps to stabilize the condition, prevent exacerbations, and maintain control over inflammation.

Using scheduled daily controller therapy allows for consistent management of asthma, reducing the risk of acute symptoms and improving overall lung function. This proactive strategy is fundamental to effective asthma care and is distinct from short-term or as-needed medications, which serve different purposes in managing asthma symptoms.

In contrast, the other options relate to different aspects of asthma management. PRN (as-needed) use refers mainly to quick-relief medications that address symptoms during asthma exacerbations, while the ACT (Asthma Control Test) measures the control of asthma but is not a therapy in itself. Short-acting bronchodilators are typically used for immediate relief and do not constitute maintenance therapy, which focuses on long-term control of the disease.